Morgan Stanley, State Street Corp, and other firms increased their holdings in Quest Diagnostics during Q2, Q3, and Q4 of 2026.
1 report, 1 independent
Updated Aug 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley, State Street Corp, and other firms increased their holdings in Quest Diagnostics during Q2, Q3, and Q4 of 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
Quest Diagnostics
medical research company
-
Boston Partners
US investment management corporation
Related events
- Morgan Stanley discussed market trends regarding Q3 earnings for J.B. Hunt Transport Services, Inc.
- Multiple financial firms, including BlackRock, UBS AM, and Legal & General Group Plc, bought new stakes in JBG SMITH Properties stock.
- Morgan Stanley issued a rating and price target for Trevi Therapeutics, Inc. on August 28, 2026.
- Morgan Stanley raised its price target for a company and disclosed selling a portion of its holdings, involving Vital Farms, Robinhood, and ARK Invest.
- Morgan Stanley boosted its position in Boston Scientific shares, while the company's board authorized a stock repurchase program.